Fig. S2
A: In vitro cleavage of MUC2-C by rCLCA1 separated on SDS-PAGE and stained with SYPRO Ruby. Different fractions from the rCLCA1 purification was tested (#17, and #9). Red arrows mark bands from CLCA1 fraction 17. B-C: In vitro cleavage of MUC2-N by rCLCA1 fraction #7 and #30 separated on SDS-PAGE and stained with SYPRO Ruby (B) or immunoblotted with αMUC2-N3 (C). D: Table  with proteins detected by mass spectrometry in rCLCA1 purification fraction #9 and #17 but not in #7 and #30. E: Immunoblotting of in vitro cleavage of MUC2-N by rCLCA1 separated on SDS-PAGE under non-reducing conditions (-DTT), using αMUC2-N3.
Fig. S3
A: Annotated spectrum with alignment, ion table and error map for N-terminally TMPP labelled peptide. IGQSCTAPK. B: Annotated spectrum with alignment, ion table and error map for N-terminally TMPP labelled peptide ATSKPR.
Fig S4
Annotated spectrum with alignment, ion table and error map for N-terminally TMPP labelled peptide RDEGHHVAYTTR
Fig. S5
A: Sequence alignment of E2, TIL´ and VWD3 from VWF, human MUC2 (hMUC2) and mouse Muc2 (mMuc2) with marked disulfide bridges based on disulfide bridges described for VWF 1 . CLCA1 cleavage sites are marked by red arrows. Furin cleavage site in VWF is marked by black arrow. B: Sequence alignment of E1, E2 and E´ from human MUC2 (hMUC2) and VWF with marked disulfide bridges based on disulfide bridges described for VWF. CLCA1 cleavage site is marked by red arrow. Table S1 . Intensity of MUC2 peptides shown in Figure 4H with marked start and end position.
Table S2.
Intensity of MUC2 peptides shown in Figure 5F with marked start position. 
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Fig. S5. A:
Sequence alignment of E2, TIL´ and VWD3 from VWF, human MUC2 (hMUC2) and mouse Muc2 (mMuc2) with marked disulfide bridges based on disulfide bridges described for VWF 1 . CLCA1 cleavage sites are marked by red arrows. Furin cleavage site in VWF is marked by black arrow. B: Sequence alignment of E1, E2 and E´ from human MUC2 (hMUC2) and VWF with marked disulfide bridges based on disulfide bridges described for VWF. CLCA1 cleavage site is marked by red arrow. 
